Pharmaceutical company Mylan has reduced the cost of EpiPens for some people after coming under fire from politicians — but at the end of the day, its CEO told CNBC on Thursday she has a business to run.
"I'm running a business," Mylan's chief executive officer, Heather Bresch, said on "Squawk Box." "We have over 600 products here in the United States that we got mid-single-digit erosion — decreases. No one was talking about price decreases, but that does happen in the industry to keep medicine affordable."
The price of the EpiPen, a lifesaving medication and delivery system for people with severe allergies, has increased more than 400 percent in the past decade, outraging many parents and prompting senators and Democratic presidential nominee Hillary Clinton to question the pricing process.